Evidence map›Paper›PMID 34768811›Full record

ReviewInternational journal of molecular sciences2021

A Promiscuous Bacterial P450: The Unparalleled Diversity of BM3 in Pharmaceutical Metabolism.

Sian Thistlethwaite, Laura N Jeffreys, Hazel M Girvan, Kirsty J McLean, Andrew W Munro

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Protein engineering: status report.Protein engineering, design & selection : PEDS · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Selective P450Journal of the American Chemical Society · 2023
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Synbiotic Compositions ofNutrients · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Sian ThistlethwaiteManchester Institute of Biotechnology, University of Manchester, 131 Princess Street, Manchester M1 7DN, UK.ORCID 0000-0002-1690-1853
Laura N JeffreysCentre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.ORCID 0000-0002-0607-6116
Hazel M GirvanDepartment of Biological and Geographical Sciences, School of Applies Sciences, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, UK.ORCID 0000-0003-2299-8644
Kirsty J McLeanDepartment of Biological and Geographical Sciences, School of Applies Sciences, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, UK.
Andrew W MunroManchester Institute of Biotechnology, University of Manchester, 131 Princess Street, Manchester M1 7DN, UK.
University of Huddersfield · GBUniversity of Manchester · GBLiverpool School of Tropical Medicine · GB

Funding

Biotechnology and Biological Sciences Research Council BB/C006879/2Biotechnology and Biological Sciences Research Council BB/M011208/1
6 · The paper itself

Abstract

CYP102A1 (BM3) is a catalytically self-sufficient flavocytochrome fusion protein isolated from

Indexed as

Bacillus megateriumBacterial ProteinsCytochrome P-450 Enzyme SystemInactivation, MetabolicNADPH-Ferrihemoprotein ReductaseBacterial ProteinsCytochrome P-450 Enzyme Systemflavocytochrome P450 BM3 monoxygenasesNADPH-Ferrihemoprotein ReductasebiocatalysisCYP102A1cytochromes P450drug metabolismP450 BM3P450 engineering

Identifiers

PMID34768811
PMCPMC8583553
OpenAlexW3210625970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.